• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化心血管健康:初级预防风险评估策略的综合综述

Optimizing Cardiovascular Health: A Comprehensive Review of Risk Assessment Strategies for Primary Prevention.

作者信息

Karwa Vineet, Wanjari Anil, Kumar Sunil, Dhondge Rushikesh H, Patil Rajvardhan, Kothari Manjeet

机构信息

Department of Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

出版信息

Cureus. 2024 Aug 6;16(8):e66341. doi: 10.7759/cureus.66341. eCollection 2024 Aug.

DOI:10.7759/cureus.66341
PMID:39246950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11379425/
Abstract

Cardiovascular disease (CVD) is a leading global health concern, and effective primary prevention strategies are essential to mitigate its impact. This comprehensive review examines current risk assessment strategies for primary prevention of CVD, emphasizing the importance of early identification and intervention to reduce disease incidence. Traditional risk factors such as hypertension, hyperlipidemia, smoking, and lifestyle choices are discussed alongside emerging factors, including genetic predispositions and biomarkers. The review evaluates various risk assessment tools and models, such as the Framingham risk score, atherosclerotic CVD risk calculator, QRISK, and Reynolds risk score, highlighting their methodologies, strengths, and limitations. Additionally, the review explores lifestyle modifications, including dietary changes, physical activity, weight management, smoking cessation, and pharmacological interventions like statins and antihypertensives. Special considerations for different populations, including the elderly, women, and those with a family history of CVD, are addressed. Future directions in cardiovascular risk assessment are also discussed, focusing on technological advancements and personalized medicine. This review aims to enhance the implementation of effective primary prevention measures and improve cardiovascular health outcomes by providing a thorough analysis of risk assessment strategies.

摘要

心血管疾病(CVD)是全球主要的健康问题,有效的一级预防策略对于减轻其影响至关重要。本综述全面审视了心血管疾病一级预防的当前风险评估策略,强调早期识别和干预对于降低疾病发病率的重要性。文中讨论了传统风险因素,如高血压、高脂血症、吸烟和生活方式选择,以及新兴因素,包括遗传易感性和生物标志物。该综述评估了各种风险评估工具和模型,如弗雷明汉风险评分、动脉粥样硬化性心血管疾病风险计算器、QRISK和雷诺兹风险评分,突出了它们的方法、优势和局限性。此外,该综述探讨了生活方式的改变,包括饮食变化、体育活动、体重管理、戒烟以及他汀类药物和抗高血压药物等药物干预措施。文中还讨论了针对不同人群的特殊考虑因素,包括老年人、女性以及有心血管疾病家族史的人群。同时也探讨了心血管风险评估的未来方向,重点是技术进步和个性化医疗。本综述旨在通过对风险评估策略进行全面分析,加强有效一级预防措施的实施,改善心血管健康状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/11379425/7d38e9f6b830/cureus-0016-00000066341-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/11379425/7d38e9f6b830/cureus-0016-00000066341-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae0/11379425/7d38e9f6b830/cureus-0016-00000066341-i01.jpg

相似文献

1
Optimizing Cardiovascular Health: A Comprehensive Review of Risk Assessment Strategies for Primary Prevention.优化心血管健康:初级预防风险评估策略的综合综述
Cureus. 2024 Aug 6;16(8):e66341. doi: 10.7759/cureus.66341. eCollection 2024 Aug.
2
Strategies for Cardiovascular Disease Prevention in Type 1 Diabetes: A Comprehensive Review.1型糖尿病患者心血管疾病预防策略:全面综述
Cureus. 2024 Aug 8;16(8):e66420. doi: 10.7759/cureus.66420. eCollection 2024 Aug.
3
Navigating Cardiovascular Risk in Type 1 Diabetes: A Comprehensive Review of Strategies for Prevention and Management.1型糖尿病中心血管风险的应对:预防与管理策略的全面综述
Cureus. 2024 May 16;16(5):e60426. doi: 10.7759/cureus.60426. eCollection 2024 May.
4
Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.适合在初级保健中实施的预防心血管疾病的实用饮食干预措施:一项基于 ADAPTE 指南的国际临床指南系统评价。
Int J Behav Nutr Phys Act. 2023 Jul 28;20(1):93. doi: 10.1186/s12966-023-01463-9.
5
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease.新兴治疗策略在心血管疾病管理中的应用综述
Curr Cardiol Rev. 2024;20(4):e160424228949. doi: 10.2174/011573403X299265240405080030.
6
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.心血管问题的考虑因素及对银屑病治疗的影响:最新综述。
Vasc Health Risk Manag. 2024 May 10;20:215-229. doi: 10.2147/VHRM.S464471. eCollection 2024.
7
Efficacy of polygenic risk scores and digital technologies for INNOvative personalized cardiovascular disease PREVention in high-risk adults: protocol of a randomized controlled trial.多基因风险评分和数字技术在高危成年人创新个性化心血管疾病预防中的疗效:一项随机对照试验的方案。
Front Public Health. 2024 Jun 14;12:1335894. doi: 10.3389/fpubh.2024.1335894. eCollection 2024.
8
A Comprehensive Review of Metabolic Syndrome and Its Role in Cardiovascular Disease and Type 2 Diabetes Mellitus: Mechanisms, Risk Factors, and Management.代谢综合征及其在心血管疾病和2型糖尿病中的作用综述:机制、危险因素与管理
Cureus. 2024 Aug 21;16(8):e67428. doi: 10.7759/cureus.67428. eCollection 2024 Aug.
9
10
Towards Optimal Cardiovascular Health: A Comprehensive Review of Preventive Strategies.迈向最佳心血管健康:预防策略的全面综述
Cureus. 2024 May 22;16(5):e60877. doi: 10.7759/cureus.60877. eCollection 2024 May.

本文引用的文献

1
2023 Australian guideline for assessing and managing cardiovascular disease risk.2023 年澳大利亚心血管疾病风险评估和管理指南。
Med J Aust. 2024 May 20;220(9):482-490. doi: 10.5694/mja2.52280. Epub 2024 Apr 16.
2
Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association.人工智能在改善心脏病治疗效果中的应用:美国心脏协会的科学声明。
Circulation. 2024 Apr 2;149(14):e1028-e1050. doi: 10.1161/CIR.0000000000001201. Epub 2024 Feb 28.
3
A Review of Smoking Cessation Interventions: Efficacy, Strategies for Implementation, and Future Directions.
戒烟干预措施综述:疗效、实施策略及未来方向
Cureus. 2024 Jan 11;16(1):e52102. doi: 10.7759/cureus.52102. eCollection 2024 Jan.
4
The Heart of the World.世界的中心。
Glob Heart. 2024 Jan 25;19(1):11. doi: 10.5334/gh.1288. eCollection 2024.
5
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.人工智能范式中心血管疾病的多基因风险评分:综述。
J Korean Med Sci. 2023 Nov 27;38(46):e395. doi: 10.3346/jkms.2023.38.e395.
6
Smartwatches in healthcare medicine: assistance and monitoring; a scoping review.智能手表在医疗保健领域的应用:辅助和监测;范围综述。
BMC Med Inform Decis Mak. 2023 Nov 3;23(1):248. doi: 10.1186/s12911-023-02350-w.
7
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.心血管-肾脏-代谢健康:美国心脏协会的总统顾问报告
Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
8
Non-Conventional Risk Factors: "Fact" or "Fake" in Cardiovascular Disease Prevention?非传统风险因素:在心血管疾病预防中是“事实”还是“假象”?
Biomedicines. 2023 Aug 23;11(9):2353. doi: 10.3390/biomedicines11092353.
9
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions.心血管成像在风险评估中的作用:最新进展、证据差距及未来方向。
J Clin Med. 2023 Aug 26;12(17):5563. doi: 10.3390/jcm12175563.
10
Impact of Lifestyle Modifications on Cardiovascular Health: A Narrative Review.生活方式改变对心血管健康的影响:一项叙述性综述
Cureus. 2023 Jul 28;15(7):e42616. doi: 10.7759/cureus.42616. eCollection 2023 Jul.